Please login to the form below

Not currently logged in


This page shows the latest PE news and features for those working in and with pharma, biotech and healthcare.

Boston Scientific makes $4.2bn play for UK’s BTG

Boston Scientific makes $4.2bn play for UK’s BTG

The US company made particular reference to BTG’s EKOS system, which in combination with clot-dissolving drugs, breaks down blood clots to restore blood flow in patients with PE, deep ... EKOS was the first device cleared by the FDA for the treatment

Latest news

More from news
Approximately 2 fully matching, plus 30 partially matching documents found.

Latest Intelligence

  • Deal Watch February 2017 Deal Watch February 2017

    Earlier in the month the private equity (PE) firm Cinven offered 56 a share to acquire Stada but this has been topped by a binding offer from another PE company, Advent ... A third suitor is believed to be another PE firm, Bain Capital.

  • Pharma deals during November 2014 Pharma deals during November 2014

    It's understood that a number of PE firms are set to acquire the diabetes portfolio, which includes Contour (the blood glucose meter) for $2.5bn.

  • Pharma deals during October 2013 Pharma deals during October 2013

    Overall there was a somewhat eclectic mix of companies featuring in the deals reported and interestingly private equity (PE) companies were involved in several of the transactions. ... The other major deal featuring PE is the acquisition of Acino by

  • Modern anticoagulants threaten status quo Modern anticoagulants threaten status quo

    2012. Rivaroxaban is also awaiting US approval for the treatment of VTE or PE, and for long-term prevention of recurrent VTE.

More from intelligence
Approximately 0 fully matching, plus 4 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
Complete HealthVizion

Complete HealthVizion is a global team of fresh thinkers who aspire to be better every day. We create life-changing medical...

Latest intelligence

The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....
Escaping the spin cycle of sub-optimal launch